Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    17346246 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting BEEP Follow Up: Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic Patients
Condition: Epilepsy
Interventions: Drug: lamotrigine (brand Lamictal);   Drug: lamotrigine (generic Teva)
2 Completed Lamotrigine Bioequivalence
Condition: Epilepsy
Intervention: Drug: lamotrigine
3 Not yet recruiting Characterization of Epilepsy Patients BEEP 2b
Condition: Epilepsy
Interventions: Drug: Oxcarbmazepine (brand name vs generic drugs);   Drug: Divalproex Sodium (brand name vs generic drugs);   Drug: Carbamazepine (brand name vs generic drugs);   Drug: Lamotrigine (brand name vs generic drugs);   Drug: levetiracetam (brand name vs generic drugs);   Drug: Topiramate (brand name vs generic drugs);   Drug: Zonisamide (brand name vs generic drugs);   Drug: Phenytoin sodium (brand name vs generic drugs)
4 Recruiting A Trial of Generic Substitution of Antiepileptic Drugs
Condition: Epilepsy
Intervention: Drug: Experimental

Study has passed its completion date and status has not been verified in more than two years.